The American Society of Nephrology (ASN) is proud to announce the upcoming launch of the ASN Loan Mitigation Pilot Program.
This exciting program will launch in early 2021, and the pilot will continue for three years. ASN has committed $2,700,000 to reaching those who are considering nephrology as a career.
In the first year of the pilot, ASN will fund six applicants, reducing the loan burden for each applicant by $50,000 over three years. Year 1 awards will center on individuals racially underrepresented in medicine. When the program launches, ASN will disseminate details regarding eligibility requirements and the application process.
Health professionals take great pride in our commitment to improving the lives of those we care for. We recognize and accept that our calling involves risk, day in and day out.
This year, facing the challenges, stress, and ongoing burden of a global pandemic, kidney professionals have demonstrated the resolve and focus on excellence that exemplifies our profession.
Physicians, scientists, nurses, advanced practice providers, technicians, and so many others have stepped into unknown territory with grace and courage. We have devised new ways to provide care, taken on additional work with resolve, and shared essential knowledge and insights with peers worldwide.
Gisela Deuter, BSN, MSA, enabled ASN to develop, launch, and build the Nephrology Self-Assessment Program (nephSAP), helped launch ASN Renal Weekends (now called ASN Highlights), expand educational offerings at ASN Kidney Week, and ensure ASN’s accreditation as a provider of continuing medical education credits by the Accreditation Council for Continuing Medical Education (ACCME). Finally, she helped start the Kidney Self-Assessment Program in 2014.
Nearly 50% of US nephrologists are international medical graduates. Their contributions improve the U.S. health system and the care of people with kidney diseases.
ASN firmly supports the dismantling of barriers that prevent foreign-trained doctors, nurses, and other health professionals from securing the stable immigration status and providing care to the millions of Americans who desperately need it.
ASN honors the 2020 Midcareer Award recipients. ASN congratulates the following individuals for their exemplary work and achievements.
Derek M. Fine, MD, and Vandana Dua Niyyar, MD, FASN, will receive the ASN Distinguished Clinical Service Award, which recognizes individuals who combine the art of medicine with the skills demanded by the scientific body of knowledge in service to patients. The award also recognizes those who exemplify leadership and excellence in the practice of nephrology and those who have initiated or been involved in volunteer programs or have provided volunteer service post-training.
In September 2020, the Centers for Medicare & Medicaid Services (CMS) and its Innovation Center (CMMI) finalized the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model. This mandatory payment model will test changes to care for Americans with kidney disease within a 30%, randomized set of Medicare beneficiaries with kidney failure.
The stated goals are increasing patient choice, increasing utilization of home dialysis, and providing greater access to transplantation, options for which the American Society of Nephrology (ASN) has long advocated.
The American Society of Nephrology (ASN) commends the Centers for Medicare and Medicaid Services (CMS) and its Innovation Center (CMMI) for finalizing the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model today. This model will herald positive changes to care for the more than 37 million Americans with kidney diseases, including more patient choice, increased utilization of home dialysis, and greater access to transplantation, options for which ASN has long advocated.
Consumer Reports (CR) recently published an article, “Medical Algorithms Have a Race Problem,” which recognized the potential impact ASN and the National Kidney Foundation (NKF) could have through their joint task force to reassess the inclusion of race in diagnosing kidney disease.
Center for Scientific Review’s Elimination of Study Section Perilous to Kidney Community
The Center for Scientific Review (CSR) at the National Institutes of Health (NIH) oversees peer review of NIH grant applications. CSR recently announced a change to study sections that will have a significant effect on the kidney community.
NIH grant applications are reviewed by content experts in study sections relevant to the application. CSR reduced the number of study sections for Gastrointestinal, Renal, Endocrine Systems by one section. Eliminating a kidney study section results in grants being assigned to broader sections that focus on issues outside of nephrology as well. This can negatively impact the quality of the review and reduce the probability of a grant being funded.
In August of 2020, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) formed a joint task force to focus on the use of race to estimate GFR. For more information, please read the joint NKF-ASN statement on “Establishing a Task Force to Reassess the Inclusion of Race in Diagnosing Kidney Diseases.”